Results 181 to 190 of about 52,744 (222)

Correction to: IgA autoantibodies demonstrate a novel mechanism of MuSK myasthenia gravis pathology. [PDF]

Brain
europepmc   +1 more source

Age and Treatment Efficacy in Myasthenia Gravis: A Systematic Review, Meta-Analysis, and Meta-Regression. [PDF]

Eur J Neurol
Nelke C, Skrobol M, Theissen L, Sacca F, Ruck T.   +4 more
europepmc   +1 more source

Association Between Statin Initiation and Myasthenia Gravis Crisis. [PDF]

J Clin Neurol
Yoo WH, Noh Y, Kim SW, Shin HY, Shin JY, Lee H.   +5 more
europepmc   +1 more source

Efgartigimod-alfa therapy in acetylcholine receptor antibody myasthenia gravis: Romanian experience. [PDF]

Front Neurol
Grecu N, Mihalache OA, Davidescu EI, Bălașa R, Simu M, Văcăraș V, Vodă IM, Mușuroi AI, Ene AM, Petrescu DM, Mitu CE, Furnică L, Cornea A, Homorodean R, Vîlciu C, Tiu C.   +15 more
europepmc   +1 more source

Identification of rs28362336 as a risk SNP for generalized myasthenia gravis and its impact on HCG27 regulation. [PDF]

PLoS One
Chen Z, Guo Q, Tian L, Jin J, Wang X, Yu C, Li Y, Zhang J, Li Y, Zhao Y, Zhang J, Zhang L, Qiao L, Wang J.   +13 more
europepmc   +1 more source

When Weakness Persists Beyond Its Apparent Cause: A Case Report of Myasthenia Gravis. [PDF]

Cureus
Ehsan N, Ahmed H, Iqbal M, Arshad M, Imran M.   +4 more
europepmc   +1 more source

Regarding: Myasthenia gravis following the initiation of statin therapy. [PDF]

J Intern Med
Zeng S, Shi Z.
europepmc   +1 more source